Techcyte Receives Health Canada License for Fusion AP Viewer

Class II medical device license expands access to Techcyte’s digital pathology solution in Canada

OREM, UT, UNITED STATES, November 19, 2026 /EINPresswire.com/ — Techcyte, the developer of Fusion, the enterprise digital pathology platform, today announced that it has received a Medical Device Licence (MDL) from Health Canada for its Fusion AP Viewer, a Class II medical device. The license authorizes the viewer to be marketed and sold to clinical laboratories and healthcare providers across Canada for its licensed intended use.

The Fusion AP Viewer combines high-speed image viewing with a flexible workspace designed to infuse AI into pathology workflows. Pathologists can review slides across multiple monitors, see AI results, view case history, and collaborate with colleagues directly within the viewer.

The viewer is part of Techcyte Fusion®, the company’s platform for whole slide viewing, case management, and integrated laboratory workflows across anatomic and clinical pathology. Fusion AP is also CE-marked under IVDR and UKCA certified. Together, these regulatory milestones support Techcyte’s continued international expansion and reflect its commitment to meeting the requirements of the markets it serves.

“This license means laboratories in Canada can adopt the Fusion AP Viewer for its licensed intended use,” said Marcus Malmberg, VP of Regulatory Affairs at Techcyte. “Meeting Health Canada’s rigorous requirements for safety, quality, and effectiveness is a source of pride for our team and reflects our commitment to delivering high-quality software and a thoughtful user experience for our customers.”

Canadian laboratories, pathology practices, and healthcare providers can request a demonstration at techcyte.com.


###


About Techcyte
Techcyte is transforming the practice of pathology through Fusion, an AI-enabled, enterprise digital platform that streamlines complex workflows, integrates with core lab systems, and enhances communication across the lab.

By partnering with leading laboratories, scanner manufacturers, diagnostic hardware providers, and AI developers, we deliver a unified digital pathology platform to labs and clinics around the world, furthering our mission to positively impact the health of humans, animals, and the environment.

Techcyte Fusion is for Research Use Only in the United States

Troy Bankhead
Techcyte
+1 435 210-6200
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery